These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
605 related articles for article (PubMed ID: 9199963)
1. The IgV domain of human B7-2 (CD86) is sufficient to co-stimulate T lymphocytes and induce cytokine secretion. Rennert P; Furlong K; Jellis C; Greenfield E; Freeman GJ; Ueda Y; Levine B; June CH; Gray GS Int Immunol; 1997 Jun; 9(6):805-13. PubMed ID: 9199963 [TBL] [Abstract][Full Text] [Related]
2. Costimulation light: activation of CD4+ T cells with CD80 or CD86 rather than anti-CD28 leads to a Th2 cytokine profile. Broeren CP; Gray GS; Carreno BM; June CH J Immunol; 2000 Dec; 165(12):6908-14. PubMed ID: 11120816 [TBL] [Abstract][Full Text] [Related]
3. Blocking CD40 - CD154 and CD80/CD86 - CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production. Van Gool SW; Vermeiren J; Rafiq K; Lorr K; de Boer M; Ceuppens JL Eur J Immunol; 1999 Aug; 29(8):2367-75. PubMed ID: 10458748 [TBL] [Abstract][Full Text] [Related]
4. Chimeric co-stimulatory molecules that selectively act through CD28 or CTLA-4 on human T cells. Lazetic S; Leong SR; Chang JC; Ong R; Dawes G; Punnonen J J Biol Chem; 2002 Oct; 277(41):38660-8. PubMed ID: 12167647 [TBL] [Abstract][Full Text] [Related]
5. B7-CD28 interaction is a late acting co-stimulatory signal for human T cell responses. Zhang YQ; Joost van Neerven RJ; Van Gool SW; Coorevits L; de Boer M; Ceuppens JL Int Immunol; 1997 Aug; 9(8):1095-102. PubMed ID: 9263006 [TBL] [Abstract][Full Text] [Related]
6. Both extracellular immunoglobin-like domains of CD80 contain residues critical for binding T cell surface receptors CTLA-4 and CD28. Peach RJ; Bajorath J; Naemura J; Leytze G; Greene J; Aruffo A; Linsley PS J Biol Chem; 1995 Sep; 270(36):21181-7. PubMed ID: 7545666 [TBL] [Abstract][Full Text] [Related]
7. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Linsley PS; Greene JL; Brady W; Bajorath J; Ledbetter JA; Peach R Immunity; 1994 Dec; 1(9):793-801. PubMed ID: 7534620 [TBL] [Abstract][Full Text] [Related]
8. Interaction of CTLA-4 (CD152) with CD80 or CD86 inhibits human T-cell activation. Vandenborre K; Van Gool SW; Kasran A; Ceuppens JL; Boogaerts MA; Vandenberghe P Immunology; 1999 Nov; 98(3):413-21. PubMed ID: 10583602 [TBL] [Abstract][Full Text] [Related]
9. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis. Melichar B; Nash MA; Lenzi R; Platsoucas CD; Freedman RS Clin Exp Immunol; 2000 Jan; 119(1):19-27. PubMed ID: 10606960 [TBL] [Abstract][Full Text] [Related]
10. B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis. Liu Z; Geboes K; Hellings P; Maerten P; Heremans H; Vandenberghe P; Boon L; van Kooten P; Rutgeerts P; Ceuppens JL J Immunol; 2001 Aug; 167(3):1830-8. PubMed ID: 11466409 [TBL] [Abstract][Full Text] [Related]
11. B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells. Caux C; Vanbervliet B; Massacrier C; Azuma M; Okumura K; Lanier LL; Banchereau J J Exp Med; 1994 Nov; 180(5):1841-7. PubMed ID: 7525840 [TBL] [Abstract][Full Text] [Related]
12. Mutational analysis and an alternatively spliced product of B7 defines its CD28/CTLA4-binding site on immunoglobulin C-like domain. Guo Y; Wu Y; Zhao M; Kong XP; Liu Y J Exp Med; 1995 Apr; 181(4):1345-55. PubMed ID: 7535334 [TBL] [Abstract][Full Text] [Related]
13. Regulation of T and B cell responses by modulating interactions between CD28/CTLA4 and their ligands, CD80 and CD86. Lane P Ann N Y Acad Sci; 1997 Apr; 815():392-400. PubMed ID: 9186685 [TBL] [Abstract][Full Text] [Related]
14. Binding stoichiometry of the cytotoxic T lymphocyte-associated molecule-4 (CTLA-4). A disulfide-linked homodimer binds two CD86 molecules. Linsley PS; Nadler SG; Bajorath J; Peach R; Leung HT; Rogers J; Bradshaw J; Stebbins M; Leytze G; Brady W J Biol Chem; 1995 Jun; 270(25):15417-24. PubMed ID: 7541042 [TBL] [Abstract][Full Text] [Related]
15. Recombinant human B7.2 IgV-like domain expressed in bacteria maintains its co-stimulatory activity in vitro. Yan X; Ma J; Zheng J; Lai B; Geng Y; Wang Y; Si L Chin Med J (Engl); 2002 Jul; 115(7):1053-7. PubMed ID: 12150742 [TBL] [Abstract][Full Text] [Related]
17. Differential requirement for CD80 and CD80/CD86-dependent costimulation in the lung immune response to an influenza virus infection. Lumsden JM; Roberts JM; Harris NL; Peach RJ; Ronchese F J Immunol; 2000 Jan; 164(1):79-85. PubMed ID: 10604996 [TBL] [Abstract][Full Text] [Related]
19. B7 requirements for primary and secondary protein- and polysaccharide-specific Ig isotype responses to Streptococcus pneumoniae. Wu ZQ; Khan AQ; Shen Y; Schartman J; Peach R; Lees A; Mond JJ; Gause WC; Snapper CM J Immunol; 2000 Dec; 165(12):6840-8. PubMed ID: 11120807 [TBL] [Abstract][Full Text] [Related]
20. Porcine CTLA4-Ig lacks a MYPPPY motif, binds inefficiently to human B7 and specifically suppresses human CD4+ T cell responses costimulated by pig but not human B7. Vaughan AN; Malde P; Rogers NJ; Jackson IM; Lechler RI; Dorling A J Immunol; 2000 Sep; 165(6):3175-81. PubMed ID: 10975832 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]